课题基金 / 基金详情

Bioreactor production of human embryonic stem cell derived osteoblasts and chondrocytes

Bioreactor production of human embryonic stem cell derived osteoblasts and chondrocytes
生物反应器生产人胚胎干细胞衍生的成骨细胞和软骨细胞
批准号:
338157-2007
负责人:
Kallos, Michael
金额:
$5.76万
依托单位:
依托单位国家:
加拿大
项目类别:
Collaborative Health Research Projects
财政年份:
2007
资助国家:
加拿大
项目状态:
已结题
起止时间:
2007-01-01 至 2008-12-31

项目摘要

项目成果

Kallos, Michael的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Musculoskeletal ailments, including osteoporosis and bone and joint injuries, currently affect several hundred million people worldwide. These conditions result in a decreased quality of life for many people and a considerable ongoing cost to health care systems. Recently, tissue engineering has emerged as a potential new alternative for treating affected individuals. Tissue engineering involves combining cells with a scaffold support to generate functional replacement tissues. In particular, the use of embryonic stem cells is being investigated as a potential source of cells to regenerate tissues. Embryonic stem cells (ESCs) can divide to form many cells, and are pluripotent, meaning mat they possess the ability to form any tissue type in the body. Recently, we have successfully generated bone and cartilage tissue in small-scale stationary cultures of mouse ESCs, which we have begun to integrate into biodegradable scaffolds. As a result of the high level of tissue demand for clinical use, many more cells will be required. We will use our success with the model (mouse) system as a basis for the proposed research, which will examine the large-scale production and differentiation, of human ESCs in computer-controlled bioreactors. Our long-term goal will be to apply our approach to the human clinical setting. Hence, one of the outcomes of this work, successful production of bone and cartilage tissue, will be highly beneficial to the thousands of Canadians who suffer from joint injuries and diseases. Our work will have worldwide implications towards the progress and advancement of the field of tissue engineering. Other immediate outcomes of the research will include the coalescence of a multidisciplinary team with expertise in bioengineering, engineering physics, biophysics, biology, and mathematics around a unique medical problem and the development of a unique training program involving biomedical engineering and stem cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Precision Bioprocess Engineering for Regenerative Medicine
  • 批准号:
    RGPIN-2017-04124
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $4.81万
  • 财政年份:
    2021
  • 负责人:
    Kallos, Michael
  • 依托单位:
Precision Bioprocess Engineering for Regenerative Medicine
  • 批准号:
    RGPIN-2017-04124
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2020
  • 负责人:
    Kallos, Michael
  • 依托单位:
Precision Bioprocess Engineering for Regenerative Medicine
  • 批准号:
    RGPIN-2017-04124
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2019
  • 负责人:
    Kallos, Michael
  • 依托单位:
Precision Bioprocess Engineering for Regenerative Medicine
  • 批准号:
    RGPIN-2017-04124
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.4万
  • 财政年份:
    2018
  • 负责人:
    Kallos, Michael
  • 依托单位:
国内基金
海外基金
交货期敏感的单件模式产品供应链的协调优化
  • 批准号:
    70871060
  • 项目类别:
    面上项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2008
  • 负责人:
    杨文胜
  • 依托单位:
供应链中生产和配送联合排序和调度的模型、算法及应用
  • 批准号:
    70372058
  • 项目类别:
    面上项目
  • 资助金额:
    14.0万元
  • 批准年份:
    2003
  • 负责人:
    万国华
  • 依托单位: